Total number of results for Mus musculus are 247
Download
as Fasta All
| NPID | Sequence | Length | Organism | Family | Name | PMID | Peptide_REF |
|---|---|---|---|---|---|---|---|
| NP00003 | SVPHFSEEEKEAE |
13 | Mus musculus | 7B2 | C-terminal peptide (By similarity) | ||
| NP00014 | YSPRTPDRVSETDIQRLLHGVMEQLGIARPRVEYPAHQAMNLVGPQSIEGGAHEGLQHLGPFGNIPNIVAELTGDNIPKDFSEDQGYPDPPNPCPLGKTADDGCLENAPDTAEFSREFQLDQHLFDPEHDYPGLGKWNKKLLYEKMKGGQRRKRRSVNPYLQGKRLDNVVAKKSVPHFSEEEKEAE |
186 | Mus musculus | 7B2 | Neuroendocrine protein 7B2 | ||
| NP00015 | YSPRTPDRVSETDIQRLLHGVMEQLGIARPRVEYPAHQAMNLVGPQSIEGGAHEGLQHLGPFGNIPNIVAELTGDNIPKDFSEDQGYPDPPNPCPLGKTADDGCLENAPDTAEFSREFQLDQHLFDPEHDYPGLGKWNKKLLYEKMKGGQ |
150 | Mus musculus | 7B2 | N-terminal peptide (By similarity) | ||
| NP00027 | MSLQADFDQAAQDVRKLKSRPEDEELKELYGLYKQSVIGDINIACPAMLDLKGKAKCEAWNLQKGLSKEDAMCAYISKARELIEKYGI |
88 | Mus musculus | ACBP | Acyl-CoA-binding domain-containing protein 7 | ||
| NP00028 | MSQVEFEMACASLKQLKGPVSDQEKLLVYSFYKQATQGDCNIPVPPATDVRAKAKYEAWMVNKGMSKMDAMRIYIAKVEELKKKEPC |
87 | Mus musculus | ACBP | Diazepam-binding inhibitor-like 5 | ||
| NP00035 | SQAEFDKAAEEVKRLKTQPTDEEMLFIYSHFKQATVGDVNTDRPGLLDLKGKAKWDSWNKLKGTSKESAMKTYVEKVDELKKKYGI |
86 | Mus musculus | ACBP | Acyl-CoA-binding protein | ||
| NP00046 | PHAQLLRVGCVLGTCQVQNLSHRLWQLVRPAGRRDSAPVDPSSPHSY |
47 | Mus musculus | Adrenomedullin | Adrenomedullin-2 (By similarity) | ||
| NP00047 | VGCVLGTCQVQNLSHRLWQLVRPAGRRDSAPVDPSSPHSY |
40 | Mus musculus | Adrenomedullin | Intermedin-short (Potential) | ||
| NP00048 | YRQSMNQGSRSNGCRFGTCTFQKLAHQIYQLTDKDKDGMAPRNKISPQGY |
50 | Mus musculus | Adrenomedullin | Adrenomedullin | ||
| NP00049 | AGPDTPSQFRKKWNKWALSR |
20 | Mus musculus | Adrenomedullin | Proadrenomedullin N-20 terminal peptide | ||
| NP00605 | QRPRLSHKGPMPF |
13 | Mus musculus | Apelin | Apelin-13 (By similarity) | ||
| NP00606 | TGPGAWQGGRRKFRRQRPRLSHKGPMPF |
28 | Mus musculus | Apelin | Apelin-28 (By similarity) | ||
| NP00607 | TSRTGPGAWQGGRRKFRRQRPRLSHKGPMPF |
31 | Mus musculus | Apelin | Apelin-31 (By similarity) | ||
| NP00608 | LVKPRTSRTGPGAWQGGRRKFRRQRPRLSHKGPMPF |
36 | Mus musculus | Apelin | Apelin-36 (By similarity) | ||
| NP00794 | APVSTGAGGGTVLAKMYPRGSHWAVGHLM |
29 | Mus musculus | Bombesin/neuromedin-B/ranatensin | Gastrin-releasing peptide | ||
| NP00795 | GSHWAVGHLM |
10 | Mus musculus | Bombesin/neuromedin-B/ranatensin | Neuromedin-C | ||
| NP00796 | GNLWATGHFM |
10 | Mus musculus | Bombesin/neuromedin-B/ranatensin | Neuromedin-B | ||
| NP00797 | APFNWDLPEPRSRASKIRVHPRGNLWATGHFM |
32 | Mus musculus | Bombesin/neuromedin-B/ranatensin | Neuromedin-B-32 | ||
| NP00814 | RPPGFSPFR |
9 | Mus musculus | Bradykinin | Bradykinin | ||
| NP00851 | CGNLSTCMLGTYTQDLNKFHTFPQTSIGVEAP |
32 | Mus musculus | Calcitonin | Calcitonin | ||
| NP00852 | SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF |
37 | Mus musculus | Calcitonin | Calcitonin gene-related peptide 1 | ||
| NP00853 | SCNTATCVTHRLADLLSRSGGVLKDNFVPTDVGSEAF |
37 | Mus musculus | Calcitonin | Calcitonin gene-related peptide 2 | ||
| NP00854 | KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY |
37 | Mus musculus | Calcitonin | Islet amyloid polypeptide | ||
| NP00871 | QEDAELQPRALDIYSAVDDASHEKELPRRQLRAPGAMLQIEALQEVLKKLKS |
52 | Mus musculus | CART | CART(1-52) (By similarity) | ||
| NP00872 | IPIYEKKYGQVPMCDAGEQCAVRKGARIGKLCDCPRGTSCNSFLLKCL |
48 | Mus musculus | CART | CART(55-102) (By similarity) | ||
| NP00873 | YGQVPMCDAGEQCAVRKGARIGKLCDCPRGTSCNSFLLKCL |
41 | Mus musculus | CART | CART(62-102) (Potential) | ||
| NP00882 | QEDAELQPRALDIYSAVDDASHEKELPRRQLRAPGAMLQIEALQEVLKKLKSKRIPIYEKKYGQVPMCDAGEQCAVRKGARIGKLCDCPRGTSCNSFLLKCL |
102 | Mus musculus | CART | Cocaine- and amphetamine-regulated | ||
| NP00914 | GSAKVAFSAIRSTNH |
15 | Mus musculus | Cerebellins | [des-Ser1]-cerebellin | ||
| NP00915 | SGSAKVAFSAIRSTNH |
16 | Mus musculus | Cerebellins | Cerebellin | 3199194# Slemmon J.R., Goldowitz D., Blacher R., Morgan J.I.; # "Evidence for the transneuronal regulation of cerebellin biosynthesis in developing Purkinje cells."; # J. Neurosci. 8:4603-4611(1988). | |
| NP00916 | QNETEPIVLEGKCLVVCDSNPTSDPTGTALGISVRSGSAKVAFSAIRSTNHEPSEMSNRTMIIYFDQVLVNIGNNFDSERSTFIAPRKGIYSFNFHVVKVYNRQTIQVSLMLNGWPVISAFAGDQDVTREAASNGVLIQMEKGDRAYLKLERGNLMGGWKYSTFSGFLVFPL |
172 | Mus musculus | Cerebellins | Cerebellin-1 | ||
| NP00917 | QNDTEPIVLEGKCLVVCDSSPSGDGAVTSSLGISVRSGSAKVAFSATRSTNHEPSEMSNRTMTIYFDQVLVNIGNHFDLASSIFVAPRKGIYSFSFHVVKVYNRQTIQVSLMQNGYPVISAFAGDQDVTREAASNGVLLLMEREDKVHLKLERGNLMGGWKYSTFSGFLVFPL |
173 | Mus musculus | Cerebellins | Cerebellin-2 | ||
| NP00918 | QEGSEPVLLEGECLVVCEPGRPTAGGPGGAALGEAPPGRVAFAAVRSHHHEPAGETGNGTSGAIYFDQVLVNEGEGFDRTSGCFVAPVRGVYSFRFHVVKVYNRQTVQVSLMLNTWPVISAFANDPDVTREAATSSVLLPLDPGDRVSLRLRRGNLLGGWKYSSFSGFLIFPL |
173 | Mus musculus | Cerebellins | Cerebellin-3 | ||
| NP00919 | QNDTEPIVLEGKCLVVCDSNPATDSKGSSSSPLGISVRAANSKVAFSAVRSTNHEPSEMSNKTRIIYFDQILVNVGNFFTLESVFVAPRKGIYSFSFHVIKVYQSQTIQVNLMLNGKPVISAFAGDKDVTREAATNGVLLYLDKEDKVYLKLEKGNLLGGWQYSTFSGFLVFPL |
174 | Mus musculus | Cerebellins | Cerebellin-4 | ||
| NP00933 | ESKDQLSEDASKVITYL |
17 | Mus musculus | Chromogranin/secretogranin | Secretogranin II | 12716136#Svensson M, Sköld K, Svenningsson P, Andren PE#Peptidomics-based discovery of novel neuropeptides#J Proteome Res 2003 Mar-Apr;2(2):213-9 | |
| NP01003 | LPVNSPMTKGDTKVMKCVLEVISDSLSKPSPMPVSPECLETLQGDERILSILRHQNLLKELQDLALQGAKERAQQPLKQQQPPKQQQQQQQQQQQEQQHSSFEDELSEVFENQSPDAKHRDAAAEVPSRDTME |
133 | Mus musculus | Chromogranin/secretogranin | Beta-granin (By similarity) | ||
| NP01004 | LPVNSPMTKGDTKVMKCVLEVISDSLSKPSPMPVSPECLETLQGDERILSILRHQNLLKELQDLALQGAKERAQQPLKQQQPPKQQQQQQQQQQQEQQHSSFEDELSEVFENQSPDAKHRDAAAEVPSRDTMEKRKDSDKGQQDGFEATTEGPRPQAFPEPNQESPMMGDSESPGEDTATNTQSPTSLPSQEHVDPQATGDSERGLSAQQQARKAKQEEKEEEEEEEAVAREKAGPEEVPTAASSSHFHAGYKAIQKDDGQSDSQAVDGDGKTEASEALPSEGKGELEHSQQEEDGEEAMVGTPQGLFPQGGKGRELEHKQEEEEEEEERLSREWEDKRWSRMDQLAKELTAEKRLEGEDDPDRSMKLSFRTRAYGFRDPGPQLRRGWRPSSREDSVEARSDFEEKKEEEGSANRRAEDQELESLSAIEAELEKVAHQLQALRRG |
445 | Mus musculus | Chromogranin/secretogranin | Chromogranin-A | ||
| NP01005 | DDGQSDSQAVDGDGKTEASEALPSEGKGELEHSQQEEDGEEAMVGTPQGLFPQG |
54 | Mus musculus | Chromogranin/secretogranin | Pancreastatin (By similarity) | ||
| NP01006 | WSRMDQLAKELTAE |
14 | Mus musculus | Chromogranin/secretogranin | WE-14 (By similarity) | ||
| NP01007 | ADEFPDFYDSEEQMGPHQEANDEKARADQRVLTAEEKKELENLAAMDLELQKIAEKFSQRG |
61 | Mus musculus | Chromogranin/secretogranin | CCB peptide (By similarity) | ||
| NP01008 | APVDNRDHNEEMVTRCIIEVLSNALSKSSVPTITPECRQVLKKSGKEVKGEEKGENQNSKFEVRLLRDPADASGTRWASSREDAGAPVEDSQGQTKVGNEKWTEGGGHSREGVDDQESLRPSNQQASKEAKIYHSEERVGKEREKEEGKIYPMGEHREDAGEEKKHIEDSGEKPNTFSNKRSEASAKKKDESVARADAHSMELEEKTHSREQSSQESGEETRRQEKPQELTDQDQSQEESQEGEEGEEGEEGEEGEEDSASEVTKRRPRHHHGRSGSNKSSYEGHPLSEERRPSPKESKEADVATVRLGEKRSHHLAHYRASEEEPEYGEESRSYRGLQYRGRGSEEDRAPRPRSEESQEREYKRNHPDSELESTANRHGEETEEERSYEGANGRQHRGRGREPGAHSALDTREEKRLLDEGHYPVRESPIDTAKRYPQSKWQEQEKNYLNYGEEGDQGRWWQQEEQLGPEESREEVRFPDRQYEPYPITEKRKRLGALFNPYFDPLQWKNSDFEKRGNPDDSFLEDEGEDRNGVTLTEKNSFPEYNYDWWERRPFSEDVNWGYEKRSFARAPQLDLKRQYDGVAELDQLLHYRKKADEFPDFYDSEEQMGPHQEANDEKARADQRVLTAEEKKELENLAAMDLELQKIAEKFSQRG |
657 | Mus musculus | Chromogranin/secretogranin | Secretogranin-1 | ||
| NP01009 | QRNQLLQKEPDLRLENVQKFPSPEMIRALEYIEKLRQQAHREESSPDYNPYQGVSVPLQLKENGEESHLAESSRDALSEDEWMRIILEALRQAENEPPSAPKENKPYALNLEKNFPVDTPDDYETQQWPERKLKHMRFPLMYEENSRENPFKRTNEIVEEQYTPQSLATLESVFQELGKLTGPSNQKRERVDEEQKLYTDDEDDVYKTNNIAYEDVVGGEDWSPIEEKIETQTQEEVRDSKENTEKNEQINEEMKRSGQLGLPDEENRRESKDQLSEDASKVITYLRRLVNAVGSGRSQSGPNGDRAARLLQKPLDSQSIYQLIEISRNLQIPPEDLIEMLKAGEKPNGLVEPEQDLELAVDLDDIPEADLDRPDMFQSKMLSKGGYPKAPGRGMVEALPDGLSVEDILNVLGMENVVNQKSPYFPNQYSQDKALMRLPYGPGKSRANQIPKVAWIPDVESRQAPYENLNDQELGEYLARMLVKYPELLNTNQLKRVPSPVSSEDDLQEEEQLEQAIKEHLGPGSSQEMERLAKVSKRIPVGSLKNEDTPNRQYLDEDMLLKVLEYLNQEQAEQGREHLAKRAMENM |
587 | Mus musculus | Chromogranin/secretogranin | Secretogranin-2 | ||
| NP01010 | TNEIVEEQYTPQSLATLESVFQELGKLTGPSNQ |
33 | Mus musculus | Chromogranin/secretogranin | Secretoneurin | 16903874#Pan H, Che FY, Peng B, Steiner DF, Pintar JE, Fricker LD#The role of prohormone convertase-2 in hypothalamic neuropeptide processing: a quantitative neuropeptidomic study#J Neurochem 2006 Sep;98(6):1763-77 | |
| NP01011 | FPKPEGSQDKSLHNRELSAERPLNEQIAEAEADKIKKAFPSESKPSESNYSSVDNLNLLRAITEKETVEKERQSIRSPPFDNQLNVEDADSTKNRKLIDEYDSTKSGLDHKFQDDPDGLHQLDGTPLTAEDIVHKIATRIYEENDRGVFDKIVSKLLNLGLITESQAHTLEDEVAEALQKLISKEANNYEETLDKPTSRTENQDGKIPEKVTPVAAVQDGFTNRENDETVSNTLTLSNGLERRTNPHREDDFEELQYFPNFYALLTSIDSEKEAKEKETLITIMKTLIDFVKMMVKYGTISPEEGVSYLENLDETIALQTKNKLEKNTTDSKSKLFPAPPEKSQEETDSTKEEAAKMEKEYGSLKDSTKDDNSNLGGKTDEATGKTEAYLEAIRKNIEWLKKHNKKGNKEDYDLSKMRDFINQQADAYVEKGILDKEEANAIKRIYSSL |
449 | Mus musculus | Chromogranin/secretogranin | Secretogranin-3 | ||
| NP01101 | EEAQEIDCNDEAVFQAVDFSLKQFNPGVKSGNQYMLHRVIEGTKTDGSPTFYSFKYLIKEGNCSAQSGLAWQDCDFKDAEEAATGECTATVGKRENEFFIVTQTCKIAPSKAPILKAYFPCIGCVHAISTDSPDLEPVLKHSIEHFNNNTDHSHLFTLRKVKSAHRQVVAGLNFDITYTIVQTNCSKERFPSLHGDCVALPNGDDGECRGNLFMDINNKIANFSQSCTLYSGDDLVEALPKPCPGCPRDIPVDSPELKEVLGHSIAQLNAENDHPFYYKIDTVKKATSQVVAGTKYVIEFIARETKCSKESNTELAEDCEIKHLGQSLDCNANVYMRPWENKVVPTVKCQALDMTEMARRPPGFSPFRSVTVQETKEGRTVSPPYIAREQEERDAETEQGPTHGHGWLHEKQIKANKNHRGHKHGHDHGHWSPRRHGLGHGHQKPHGLGHGHQLKLDYLRHQREDGDDHTHTVGHGHGHGHGHGHGHGHGHGHGHGHGHGHGHGKHTNKDKNSVKQTTQRTESLASSSEYSTTSTQMQGRTEGPTLTPPRAQPTVTSSGFQDSDFIEDVVATTPPYDTGAHDDLIPDIHVQPDSLSFKLISDFPEATSPKCPGRPWKPASWEDPNTETTEFSDFDLLDALS |
641 | Mus musculus | Cystatin | Kininogen-1 | ||
| NP01102 | EEAQEIDCNDEAVFQAVDFSLKQFNPGVKSGNQYMLHRVIEGTKTDGSPTFYSFKYLIKEGNCSAQSGLAWQDCDFKDAEEAATGECTATVGKRENEFFIVTQTCKIAPSKAPILKAYFPCIGCVHAISTDSPDLEPVLKHSIEHFNNNTDHSHLFTLRKVKSAHRQVVAGLNFDITYTIVQTNCSKERFPSLHGDCVALPNGDDGECRGNLFMDINNKIANFSQSCTLYSGDDLVEALPKPCPGCPRDIPVDSPELKEVLGHSIAQLNAENDHPFYYKIDTVKKATSQVVAGTKYVIEFIARETKCSKESNTELAEDCEIKHLGQSLDCNANVYMRPWENKVVPTVKCQALDMTEMAR |
359 | Mus musculus | Cystatin | Kininogen-1 heavy chain | ||
| NP01103 | SVTVQETKEGRTVSPPYIAREQEERDAETEQGPTHGHGWLHEKQIKANKNHRGHKHGHDHGHWSPRRHGLGHGHQKPHGLGHGHQLKLDYLRHQREDGDDHTHTVGHGHGHGHGHGHGHGHGHGHGHGHGHGHGHGKHTNKDKNSVKQTTQRTESLASSSEYSTTSTQMQGRTEGPTLTPPRAQPTVTSSGFQDSDFIEDVVATTPPYDTGAHDDLIPDIHVQPDSLSFKLISDFPEATSPKCPGRPWKPASWEDPNTETTEFSDFDLLDALS |
273 | Mus musculus | Cystatin | Kininogen-1 light chain | ||
| NP01129 | CSCSSLMDKECVYFCHLDIIW |
21 | Mus musculus | Endothelin/sarafotoxin | Endothelin-1 | ||
| NP01130 | CSCNSWLDKECVYFCHLDIIW |
21 | Mus musculus | Endothelin/sarafotoxin | Endothelin-2 | ||
| NP01131 | CTCFTYKDKECVYYCHLDIIW |
21 | Mus musculus | Endothelin/sarafotoxin | Endothelin-3 | ||
| NP01224 | AGEGLSSPFWSLAPQRF |
17 | Mus musculus | FMRFamide related peptide | Neuropeptide AF | 2067975#Kavaliers M, Yang HY#Effects of mammalian FMRF-NH2-related peptides and IgG from antiserum against them on aggression and defeat-induced analgesia in mice#Peptides 1991 Mar-Apr;12(2):235-9 | |
| NP01225 | FLQPQRF |
7 | Mus musculus | FMRFamide related peptide | Neuropeptide FF | 8233035#Kavaliers M, Colwell DD#Neuropeptide FF (FLQPQRFamide) and IgG from neuropeptide FF antiserum affect spatial learning in mice#Neurosci Lett 1993 Jul 9;157(1):75-8 | |
| NP01226 | SLAAPQRF |
8 | Mus musculus | FMRFamide related peptide | Neuropeptide SF | 22580381#Kotlinska JH, Gibula-Bruzda E, Suder P, Wasielak M, Bray L, Raoof H, Bodzon-Kulakowska A, Silberring J#Crypteins derived from the mouse neuropeptide FF (NPFF)A precursor display NPFF-like effects in nociceptive tests in mice#Peptides 2012 Jul;36(1):17-22 | |
| NP01851 | QFWSLAAPQRF |
11 | Mus musculus | FMRFamide related peptide | Neuropeptide AF-like | ||
| NP01852 | FLFQPQRF |
8 | Mus musculus | FMRFamide related peptide | Neuropeptide FF | ||
| NP01853 | SPAFLFQPQRF |
11 | Mus musculus | FMRFamide related peptide | Neuropeptide SF | ||
| NP01854 | SVSFQELKDWGAKNVIKMSPAPANKVPHSAANLPLRF |
37 | Mus musculus | FMRFamide related peptide | Neuropeptide NPSF (Potential) | ||
| NP01855 | VNMEAGTRSHFPSLPQRF |
18 | Mus musculus | FMRFamide related peptide | Neuropeptide NPVF (Potential) | ||
| NP01856 | VPHSAANLPLRF |
12 | Mus musculus | FMRFamide related peptide | Neuropeptide RFRP-1 (Potential) | ||
| NP02027 | GWTLNSAGYLLGPHAIDNHRSFSDKHGLT |
29 | Mus musculus | Galanin | Galanin (By similarity) | ||
| NP02028 | ELQLEVEERRPGSVDVPLPESNIVRTIMEFLSFLHLKEAGALDSLPGIPLATSSEDLEKS |
60 | Mus musculus | Galanin | Galanin message-associated peptide (Bysimilarity) | ||
| NP02038 | APAHRGRGGWTLNSAGYLLGPVLPVSSKADQGRKRDSALEILDLWKIIDGLPYSHSPRMT |
60 | Mus musculus | Galanin | Galanin-like peptide | ||
| NP02045 | AVQKVDGEPRAHLGALLARYIQQARKAPSGRMSVIKNLQSLDPSHRISDRDYMGWMDF |
58 | Mus musculus | Gastrin/cholecystokinin | Cholecystokinin-58 | 16904071#Reeve JR Jr, Rosenquist GL, Keire DA, Chew P, Nicholas HB, Davis MT Jr, Lee TD, Shively JE, Backus RC#Crucial role of position 40 for interactions of CCK-58 revealed by sequence of cat CCK-58#Biochem Biophys Res Commun 2006 Sep 29;348(3):819-25 | |
| NP02259 | QPVVPAEATDPVEQRAQEAPRRQLRAVLRTDGEPRARLGALLARYIQQVRKAPSGRMSVLKNLQSLDPSHRISDRDYMGWMDFGRRSAEDYEYPS |
95 | Mus musculus | Gastrin/cholecystokinin | Cholecystokinin | ||
| NP02260 | ISDRDYMGWMDF |
12 | Mus musculus | Gastrin/cholecystokinin | Cholecystokinin-12 | ||
| NP02261 | KAPSGRMSVLKNLQSLDPSHRISDRDYMGWMDF |
33 | Mus musculus | Gastrin/cholecystokinin | Cholecystokinin-33 | ||
| NP02262 | DYMGWMDF |
8 | Mus musculus | Gastrin/cholecystokinin | Cholecystokinin-8 | ||
| NP02263 | QLGPQGPQHFIADLSKKQRPRMEEEEEAYGWMDF |
34 | Mus musculus | Gastrin/cholecystokinin | Big gastrin | ||
| NP02264 | QRPRMEEEEEAYGWMDF |
17 | Mus musculus | Gastrin/cholecystokinin | Gastrin | ||
| NP02265 | SWKPRSQLQDASSGPGTNEDLEQRQFNKLGSASHHRRQLGPQGPQHFIADLSKKQRPRMEEEEEAYGWMDF |
71 | Mus musculus | Gastrin/cholecystokinin | Gastrin-71 | ||
| NP02482 | MSNSRKMSEPPRFFVGPEDAEINPGNYRRFFHHAEEEEEEEDESPPERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEIILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRRDVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAEDIPIVPTTSGTMMELRCVIAVIRHGDRTPKQKMKMEVRHQKFFDLFEKCDGYKSGKLKLKKPKQLQEVLDIARQLLMELGQNNDSEIEENKSKLEQLKTVLEMYGHFSGINRKVQLTYLPHGCPKTSSEEEDNRREEPSLLLVLKWGGELTPAGRVQAEELGRAFRCMYPGGQGDYAGFPGCGLLRLHSTYRHDLKIYASDEGRVQMTAAAFAKGLLALEGELTPILVQMVKSANMNGLLDSDSDSLSSCQQRVKARLHEILQKDRDFTAEDYEKLTPSGSISVIKSMHLIKNPVKTCDKVYSLIQSLTSQIRYRMEDPKSADIQLYHSETLELMLRRWSKLEKDFKTKNGRYDISKIPDIYDCIKYDVQHNGSLKLENTMELYRLSKALADIVIPQEYGITKAEKLEIAKGYCTPLVRKIRSDLQRTQDDDTVNKLHPVYSRGVLSPERHVRTRLYFTSESHVHSLLSILRYGALCDDSKDEQWKRAMDYLNVVNELNYMTQIVIMLYEDPNKDLSSEERFHVELHFSPGAKGCEEDKNLPSGYGYRPASRENEGRRSLKTDDDEPHTSKRDEVDRAVMLFKPLVSEPIHIHRKSPLPRSRKITANEVVSENANYLRTPRNLVEQKQNPTVGFELYSMVPSICPLETLHNALFLKQVDDFLASIASPSTEVLRKVPEMSSMATRSSPGMRRKISLNTYTPTKILPTPPAALKSSKASSKAAAGGPSQAMAPHTSSRKKSINSKTEGHEPKKSTGKKR |
1129 | Mus musculus | Glucagon | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | ||
| NP02483 | YAEGTFISDYSIAMDKIRQQDFVNWLLAQRGKKSDWKHNITQ |
42 | Mus musculus | Glucagon | Gastric inhibitory polypeptide | ||
| NP02484 | HALQDTEENPRSFPASQTEAHEDPDEMNEDKRHSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIA |
69 | Mus musculus | Glucagon | Glicentin (By similarity) | ||
| NP02485 | HALQDTEENPRSFPASQTEAHEDPDEMNED |
30 | Mus musculus | Glucagon | Glicentin-related polypeptide (By similarity) | ||
| NP02486 | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
29 | Mus musculus | Glucagon | Glucagon (By similarity) | ||
| NP02487 | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG |
37 | Mus musculus | Glucagon | Glucagon-like peptide 1 (By similarity) | ||
| NP02488 | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR |
30 | Mus musculus | Glucagon | Glucagon-like peptide 1(7-36) (By similarity) | ||
| NP02489 | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG |
31 | Mus musculus | Glucagon | Glucagon-like peptide 1(7-37) (By similarity) | ||
| NP02490 | HADGSFSDEMSTILDNLATRDFINWLIQTKITD |
33 | Mus musculus | Glucagon | Glucagon-like peptide 2 (By similarity) | ||
| NP02491 | HSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIA |
37 | Mus musculus | Glucagon | Oxyntomodulin (By similarity) | ||
| NP02492 | DVAHEILNEAYRKVLDQLSARKYLQSVVARGAGENLGGSAVDDPAPLT |
48 | Mus musculus | Glucagon | PACAP-related peptide | ||
| NP02493 | HSDGIFTDSYSRYRKQMAVKKYLAAVL |
27 | Mus musculus | Glucagon | Pituitary adenylate cyclase-activating polypeptide 27 | ||
| NP02494 | HSDGIFTDSYSRYRKQMAVKKYLAAVLG |